Form 4: Biogen Executive Priya Singhal Reports Stock Transactions

Priya Singhal, Head of Development at Biogen, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• Priya Singhal, Head of Development at Biogen, filed a Form 4 on February 12, 2025, reporting transactions that occurred on February 10, 2025.
• These transactions involved common stock and restricted stock units (RSUs).
• 1,212 Restricted Stock Units vested and were converted to common stock.
• 357 shares were disposed of to cover tax obligations at a price of $142.54 per share.
• Following these transactions, Singhal directly owns 9,066.4761 shares of Biogen common stock.

Sentiment

Score: 5

Explanation: This is a routine transaction filing, indicating standard compensation practices. It doesn't inherently suggest positive or negative sentiment regarding the company's performance.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on the stock's performance.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the vesting of previously granted equity compensation.
• The tax withholding impacts the executive's personal finances.

Key Dates

Keywords

Form 4, Biogen, BIIB, Priya Singhal, Stock, Restricted Stock Units, RSU, Vesting, Tax Withholding, Head of Development, Beneficial Ownership